No Data
No Data
ALX Oncology to Host Virtual R&D Day on March 5, 2025
ALX Oncology Is Maintained at Buy by UBS
A Quick Look at Today's Ratings for ALX Oncology(ALXO.US), With a Forecast Between $3 to $5
Express News | Cantor Fitzgerald Reiterates Overweight on ALX Oncology Holdingsto Overweight
Hold Rating for ALX Oncology Amid Mixed ASPEN-06 Study Results and Financial Concerns
Stifel Nicolaus Sticks to Its Hold Rating for ALX Oncology Holdings (ALXO)
Unlock the Full List